Liquidia Corp (LQDA)
10.43
+0.28
(+2.76%)
USD |
NASDAQ |
Nov 22, 12:02
Liquidia Shareholders Equity (Quarterly): 110.52M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 110.52M |
June 30, 2024 | 62.72M |
March 31, 2024 | 86.26M |
December 31, 2023 | 47.29M |
September 30, 2023 | 48.01M |
June 30, 2023 | 60.66M |
March 31, 2023 | 81.64M |
December 31, 2022 | 90.42M |
September 30, 2022 | 95.03M |
June 30, 2022 | 102.11M |
March 31, 2022 | 55.39M |
December 31, 2021 | 65.26M |
September 30, 2021 | 72.96M |
June 30, 2021 | 79.02M |
Date | Value |
---|---|
March 31, 2021 | 62.91M |
December 31, 2020 | 71.09M |
September 30, 2020 | 65.28M |
June 30, 2020 | 8.870M |
March 31, 2020 | 21.77M |
December 31, 2019 | 34.95M |
September 30, 2019 | 19.55M |
June 30, 2019 | 32.09M |
March 31, 2019 | 37.32M |
December 31, 2018 | 18.69M |
September 30, 2018 | 27.86M |
June 30, 2018 | -12.91M |
March 31, 2018 | -4.010M |
December 31, 2017 | -33.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.870M
Minimum
Jun 2020
110.52M
Maximum
Sep 2024
66.11M
Average
65.27M
Median
Shareholders Equity (Quarterly) Benchmarks
United Therapeutics Corp | 6.101B |
Arcturus Therapeutics Holdings Inc | 261.87M |
Paragon 28 Inc | 139.43M |
Tonix Pharmaceuticals Holding Corp | 74.21M |
AIM ImmunoTech Inc | 2.912M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 252.89M |
Total Liabilities (Quarterly) | 142.37M |
Current Ratio | 6.330 |